Teva Pharmaceutical Industries Limited (BVMF:T1EV34)

BVMF:T1EV34 Statistics

Total Valuation

BVMF:T1EV34 has a market cap or net worth of BRL 156.94 billion. The enterprise value is 235.80 billion.

Market Cap	156.94B
Enterprise Value	235.80B

Important Dates

The last earnings date was Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.33%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.14B

Valuation Ratios

The trailing PE ratio is 41.30 and the forward PE ratio is 9.74.

PE Ratio	41.30
Forward PE	9.74
PS Ratio	1.76
PB Ratio	4.06
P/TBV Ratio	n/a
P/FCF Ratio	50.95
P/OCF Ratio	27.62
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.44, with an EV/FCF ratio of 76.55.

EV / Earnings	62.06
EV / Sales	2.65
EV / EBITDA	9.44
EV / EBIT	12.49
EV / FCF	76.55

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 2.36.

Current Ratio	1.11
Quick Ratio	0.52
Debt / Equity	2.36
Debt / EBITDA	3.62
Debt / FCF	29.57
Interest Coverage	3.73

Financial Efficiency

Return on equity (ROE) is 9.71% and return on invested capital (ROIC) is 8.90%.

Return on Equity (ROE)	9.71%
Return on Assets (ROA)	5.45%
Return on Invested Capital (ROIC)	8.90%
Return on Capital Employed (ROCE)	12.55%
Revenue Per Employee	2.57M
Profits Per Employee	109,226
Employee Count	35,686
Asset Turnover	0.41
Inventory Turnover	2.30

Taxes

In the past 12 months, BVMF:T1EV34 has paid 1.27 billion in taxes.

Income Tax	1.27B
Effective Tax Rate	26.44%

Stock Price Statistics

The stock price has increased by +27.15% in the last 52 weeks. The beta is 0.70, so BVMF:T1EV34's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+27.15%
50-Day Moving Average	49.97
200-Day Moving Average	50.05
Relative Strength Index (RSI)	75.22
Average Volume (20 Days)	26

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.51

Income Statement

In the last 12 months, BVMF:T1EV34 had revenue of BRL 89.41 billion and earned 3.80 billion in profits. Earnings per share was 3.29.

Revenue	89.41B
Gross Profit	44.78B
Operating Income	18.97B
Pretax Income	4.80B
Net Income	3.80B
EBITDA	24.36B
EBIT	18.97B
Earnings Per Share (EPS)	3.29

Balance Sheet

The company has 11.74 billion in cash and 91.08 billion in debt, giving a net cash position of -79.34 billion.

Cash & Cash Equivalents	11.74B
Total Debt	91.08B
Net Cash	-79.34B
Net Cash Per Share	n/a
Equity (Book Value)	38.66B
Book Value Per Share	33.68
Working Capital	6.64B

Cash Flow

In the last 12 months, operating cash flow was 5.68 billion and capital expenditures -2.60 billion, giving a free cash flow of 3.08 billion.

Operating Cash Flow	5.68B
Capital Expenditures	-2.60B
Free Cash Flow	3.08B
FCF Per Share	n/a

Margins

Gross margin is 50.09%, with operating and profit margins of 21.22% and 4.25%.

Gross Margin	50.09%
Operating Margin	21.22%
Pretax Margin	5.36%
Profit Margin	4.25%
EBITDA Margin	27.25%
EBIT Margin	21.22%
FCF Margin	3.45%

Dividends & Yields

BVMF:T1EV34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.33%
Shareholder Yield	-2.33%
Earnings Yield	2.42%
FCF Yield	1.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:T1EV34 has an Altman Z-Score of 0.62 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.62
Piotroski F-Score	7